# T3 Defense Inc.: financial statements, quarterly

DFNS · Nasdaq · CIK 1787518 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dfns.md) · [Financials](/companies/dfns/financials.md) · [Filings](/companies/dfns/filings.md) · [Insiders](/companies/dfns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dfns/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.1 d](/filings/0001213900-25-031620.md) | [5.2](/filings/0001013762-24-002177.md) | [0.3](/filings/0001213900-24-068918.md) | [0.2](/filings/0001213900-24-077772.md) | [0.2 d](/filings/0001213900-25-031620.md) | not reported | not reported | [0.0](/filings/0001185185-26-003604.md) | not reported | not reported | [3.7](/filings/0001213900-26-059606.md) | [4.0](/filings/0001185185-26-003604.md) |
| Cost of revenue | $m | [5.4 d](/filings/0001213900-25-031620.md) | [4.8](/filings/0001013762-24-002177.md) | [0.1](/filings/0001213900-24-068918.md) | [0.0](/filings/0001213900-24-077772.md) | [0.0 d](/filings/0001213900-25-031620.md) | not reported | not reported | [0.0](/filings/0001185185-26-003604.md) | not reported | not reported | [3.3](/filings/0001213900-26-059606.md) | [3.0](/filings/0001185185-26-003604.md) |
| Gross profit | $m | [(0.3) d](/filings/0001213900-25-031620.md) | [0.5](/filings/0001013762-24-002177.md) | [0.2](/filings/0001213900-24-068918.md) | [0.1](/filings/0001213900-24-077772.md) | [0.2 d](/filings/0001213900-25-031620.md) | not reported | not reported | [0.0](/filings/0001185185-26-003604.md) | not reported | not reported | [0.4](/filings/0001213900-26-059606.md) | [1.0](/filings/0001185185-26-003604.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001185185-26-003604.md) | not reported | not reported | [0.3](/filings/0001213900-26-059606.md) | [0.3](/filings/0001185185-26-003604.md) |
| Operating income | $m | [(0.1)](/filings/0001213900-23-088733.md) | [(2.8)](/filings/0001213900-25-041141.md) | [(2.1)](/filings/0001213900-25-047386.md) | [(1.0)](/filings/0001213900-25-076794.md) | [(1.2)](/filings/0001213900-25-111026.md) | [(4.5)](/filings/0001213900-26-041888.md) | [(1.5)](/filings/0001213900-26-059606.md) | [(1.0)](/filings/0001185185-26-003604.md) | [(4.8)](/filings/0001213900-25-111026.md) | [(25.3) d](/filings/0001213900-26-041888.md) | [(3.8)](/filings/0001213900-26-059606.md) | [(3.4)](/filings/0001185185-26-003604.md) |
| Interest expense | $m | not reported | [0.0](/filings/0001013762-24-002177.md) | [0.0](/filings/0001213900-24-068918.md) | [0.0](/filings/0001213900-25-076794.md) | [0.3](/filings/0001213900-25-111026.md) | [0.4](/filings/0001213900-26-041888.md) | [0.2](/filings/0001213900-25-047386.md) | [0.2](/filings/0001185185-26-003604.md) | [0.0](/filings/0001213900-25-111026.md) | [(0.3) d](/filings/0001213900-26-041888.md) | [0.4](/filings/0001213900-26-059606.md) | [0.8](/filings/0001185185-26-003604.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001185185-26-003604.md) | not reported | not reported | [0.0](/filings/0001213900-26-059606.md) | [(0.2)](/filings/0001185185-26-003604.md) |
| Net income | $m | [(0.1)](/filings/0001213900-23-088733.md) | [(8.9)](/filings/0001213900-25-041141.md) | [(2.4)](/filings/0001213900-25-111026.md) | [(1.6)](/filings/0001213900-25-111026.md) | [4.5](/filings/0001213900-25-111026.md) | [(161)](/filings/0001213900-26-041888.md) | [103](/filings/0001213900-26-059606.md) | [3.0](/filings/0001185185-26-003604.md) | [(16.4)](/filings/0001213900-25-111026.md) | [(11.1) d](/filings/0001213900-26-041888.md) | [(27.1)](/filings/0001213900-26-059606.md) | [(81.4)](/filings/0001185185-26-003604.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001213900-23-088733.md) | [(6.76)](/filings/0001213900-25-041141.md) | [(0.17)](/filings/0001213900-24-068918.md) | [(0.90)](/filings/0001213900-25-076794.md) | [2.18](/filings/0001213900-25-111026.md) | [(51.96)](/filings/0001213900-26-041888.md) | [18.15](/filings/0001213900-26-059606.md) | [67.50](/filings/0001185185-26-003604.md) | [(2.02)](/filings/0001213900-25-111026.md) | not reported | [(1.14)](/filings/0001213900-26-059606.md) | [(173.80)](/filings/0001185185-26-003604.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0001213900-23-088733.md) | [(6.76)](/filings/0001213900-25-041141.md) | [(1.38)](/filings/0001213900-25-047386.md) | [(0.90)](/filings/0001213900-25-076794.md) | [2.18](/filings/0001213900-25-111026.md) | [(51.96)](/filings/0001213900-26-041888.md) | [20.76](/filings/0001213900-26-059606.md) | [72.50](/filings/0001185185-26-003604.md) | [(2.02)](/filings/0001213900-25-111026.md) | not reported | [(1.01)](/filings/0001213900-26-059606.md) | [(173.80)](/filings/0001185185-26-003604.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-10-31) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.2](/filings/0001013762-24-002177.md) | [0.3](/filings/0001213900-24-068918.md) | [0.0](/filings/0001213900-24-077772.md) | [0.0](/filings/0001213900-25-041141.md) | [6.9](/filings/0001213900-26-041888.md) | [4.5](/filings/0001213900-25-047386.md) | [1.5](/filings/0001213900-25-076794.md) | [7.6](/filings/0001213900-25-111026.md) | [2.6](/filings/0001185185-26-003604.md) | [6.4](/filings/0001213900-26-059606.md) | [4.1](/filings/0001185185-26-003604.md) |
| Current assets | $m | not reported | [2.0](/filings/0001013762-24-002177.md) | [0.8](/filings/0001213900-24-068918.md) | [0.7](/filings/0001213900-24-077772.md) | [1.0](/filings/0001213900-25-041141.md) | [9.1](/filings/0001213900-26-041888.md) | [8.5](/filings/0001213900-25-047386.md) | [7.0](/filings/0001213900-25-076794.md) | [13.1](/filings/0001213900-25-111026.md) | [13.6](/filings/0001185185-26-003604.md) | [22.8](/filings/0001213900-26-059606.md) | [21.2](/filings/0001185185-26-003604.md) |
| Total assets | $m | not reported | [2.4](/filings/0001013762-24-002177.md) | [1.2](/filings/0001213900-24-068918.md) | [1.1](/filings/0001213900-24-077772.md) | [1.0](/filings/0001213900-25-041141.md) | [9.1](/filings/0001213900-26-041888.md) | [8.6](/filings/0001213900-25-047386.md) | [7.1](/filings/0001213900-25-076794.md) | [13.3](/filings/0001213900-25-111026.md) | [202](/filings/0001185185-26-003604.md) | [315](/filings/0001213900-26-059606.md) | [316](/filings/0001185185-26-003604.md) |
| Current liabilities | $m | not reported | [11.6](/filings/0001013762-24-002177.md) | [11.8](/filings/0001213900-24-068918.md) | [12.1](/filings/0001213900-24-077772.md) | [7.1](/filings/0001213900-25-041141.md) | [171](/filings/0001213900-26-041888.md) | [64.7](/filings/0001213900-25-047386.md) | [60.4](/filings/0001213900-25-076794.md) | [43.6](/filings/0001213900-25-111026.md) | [43.5](/filings/0001185185-26-003604.md) | [91.6](/filings/0001213900-26-059606.md) | [153](/filings/0001185185-26-003604.md) |
| Total liabilities | $m | not reported | [12.3](/filings/0001013762-24-002177.md) | [12.8](/filings/0001213900-24-068918.md) | [13.4](/filings/0001213900-24-077772.md) | [8.1](/filings/0001213900-25-041141.md) | [172](/filings/0001213900-26-041888.md) | [65.8](/filings/0001213900-25-047386.md) | [60.5](/filings/0001213900-25-076794.md) | [43.7](/filings/0001213900-25-111026.md) | [45.2](/filings/0001185185-26-003604.md) | [98.4](/filings/0001213900-26-059606.md) | [160](/filings/0001185185-26-003604.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [3.3](/filings/0001213900-25-031620.md) | [1.6](/filings/0001213900-25-047386.md) | [1.6](/filings/0001213900-25-047386.md) | [1.6](/filings/0001213900-25-076794.md) | [1.6](/filings/0001213900-25-111026.md) | not reported | [3.1](/filings/0001213900-26-059606.md) | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001185185-26-003604.md) | [4.2](/filings/0001213900-26-059606.md) | [4.5](/filings/0001185185-26-003604.md) |
| Shareholders' equity | $m | [(6.2)](/filings/0001013762-24-002177.md) | [(9.9)](/filings/0001213900-25-111026.md) | [(11.5)](/filings/0001213900-25-111026.md) | [(12.2)](/filings/0001213900-25-111026.md) | [(7.1)](/filings/0001213900-25-111026.md) | [(163)](/filings/0001213900-26-041888.md) | [(57.2)](/filings/0001213900-25-111026.md) | [(53.4)](/filings/0001213900-25-111026.md) | [(30.4)](/filings/0001213900-25-111026.md) | [(19.8)](/filings/0001185185-26-003604.md) | [36.2](/filings/0001213900-26-059606.md) | [(25.3)](/filings/0001185185-26-003604.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(606) d](/filings/0001213900-25-041141.md) | [(738)](/filings/0001213900-25-041141.md) | [(1,123)](/filings/0001213900-25-047386.md) | [(741) d](/filings/0001213900-24-077772.md) | [(1,199) d](/filings/0001213900-26-041888.md) | [(340)](/filings/0001213900-26-041888.md) | [(1,342)](/filings/0001213900-26-059606.md) | [(1,352) d](/filings/0001185185-26-003604.md) | [(2,505) d](/filings/0001213900-25-111026.md) | [(999) d](/filings/0001213900-26-041888.md) | [(4,927)](/filings/0001213900-26-059606.md) | [(4,864) d](/filings/0001185185-26-003604.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | [10.0](/filings/0001213900-26-059606.md) | [5.0 d](/filings/0001185185-26-003604.md) | [3.7 d](/filings/0001213900-25-111026.md) | [12.3 d](/filings/0001213900-26-041888.md) | [154](/filings/0001213900-26-059606.md) | [26.0 d](/filings/0001185185-26-003604.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [297](/filings/0001213900-26-059606.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.1](/filings/0001213900-24-077772.md) | [1.9](/filings/0001213900-23-088733.md) | [1.3](/filings/0001213900-25-041141.md) | [14.0](/filings/0001213900-24-068918.md) | [1.8](/filings/0001213900-25-076794.md) | [2.0](/filings/0001213900-25-111026.md) | [3.1](/filings/0001213900-26-041888.md) | [5.7](/filings/0001213900-26-059606.md) | [0.0](/filings/0001185185-26-003604.md) | [8.1](/filings/0001213900-25-111026.md) | [30.9](/filings/0001213900-26-059606.md) | [0.5](/filings/0001185185-26-003604.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,663,806 at 2026-08-14, from the cover of the [10-Q filed 2026-08-18](/filings/0001185185-26-003604.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.